Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;6(2):e2255838.
doi: 10.1001/jamanetworkopen.2022.55838.

Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients

Shaan Khurshid  1   2 , Jeffrey M Ashburner  3   4 , Patrick T Ellinor  1   2 , David D McManus  5 , Steven J Atlas  3   4 , Daniel E Singer  3   4 , Steven A Lubitz  1   2
Affiliations

Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients

Shaan Khurshid et al. JAMA Netw Open. .
No abstract available

Plain language summary

This cohort study is a secondary analysis of the VITAL-AF trial and assesses the prevalence and incidence of atrial fibrillation among the trial’s control participants.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Ellinor reported receiving personal fees from Bayer AG and Novartis and grants from IBM and Bayer AG during the conduct of the study. Dr McManus reported receiving personal fees from Fitbit Inc during the conduct of the study and serving on the scientific boards of Bristol Myers Squibb and Pfizer, serving on the data safety and monitoring boards of Avania and Boston Biomedical, serving as a reviewer for Venturewell, serving as an editor for the Heart Rhythm Society, receiving grants from Boehringer Ingelheim and the National Institutes of Health, and receiving nonfinancial support from Apple Computers. Dr Atlas reported receiving grants and personal fees from Bristol Myers Squibb, personal fees from Pfizer and Fitbit Inc, and grants from the American Heart Association outside the submitted work. Dr Singer reported receiving personal fees from Bristol Myers Squibb, Fitbit Inc, Medtronic, and Pfizer outside the submitted work. Dr Lubitz reported receiving personal fees from Bristol Myers Squibb, Pfizer, Invitae, and Blackstone Life Sciences, receiving grants from Boehringer Ingelheim, Fitbit Inc, Medtronic, Premier, and IBM, and being employed by the Novartis Institutes for BioMedical Research Employment as of July 18, 2022, outside the submitted work. No other disclosures were reported.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lubitz SA, Atlas SJ, Ashburner JM, et al. Screening for atrial fibrillation in older adults at primary care visits: the VITAL-AF randomized controlled trial. Circulation. 2022;145(13):946–954. doi:10.1161/CIRCULATIONAHA.121.057014 - DOI - PMC - PubMed
    1. Ashburner JM, Singer DE, Lubitz SA, Borowsky LH, Atlas SJ. Changes in use of anticoagulation in patients with atrial fibrillation within a primary care network associated with the introduction of direct oral anticoagulants. Am J Cardiol. 2017;120(5):786–791. doi:10.1016/j.amjcard.2017.05.055 - DOI - PubMed
    1. Piccini JP, Hammill BG, Sinner MF, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993–2007. Circ Cardiovasc Qual Outcomes. 2012;5(1):85–93. doi:10.1161/CIRCOUTCOMES.111.962688 - DOI - PMC - PubMed
    1. Heeringa J, van der Kuip DAM, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–953. doi:10.1093/eurheartj/ehi825 - DOI - PubMed
    1. Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–162. doi:10.1016/S0140-6736(14)61774-8 - DOI - PMC - PubMed

Publication types